HHS secretary nominee Alex Azar tells Senate panel that reducing drug prices would be his top priority

If he’s confirmed as secretary of the Department of Health and Human Services, Alex Azar vowed that he would work to lower escalating drug prices. The former head of pharmaceutical giant Eli Lilly’s U.S. operation told a Senate committee during his confirmation hearing this morning that “drug prices are too high” and the costs must be more affordable.“The president has made this clear, so have I,” he said.

Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive